Current Headlines

  1. New Initiative Launched To Promote Biotech Education
    10/22/2014

    The Biogen Idec Foundation is offering up a $1.5 million grant in an effort to boost the biotechnology industry’s visibility.

  2. University Of Pennsylvania’s T-Cell Therapy Shows Promising Results
    10/22/2014

    The University of Pennsylvania has announced promising results of its novel chimeric antigen receptor (CAR) therapy for cancer.

  3. Lilly To Streamline Manufacturing Operations In 2015
    10/21/2014

    Eli Lilly announced its plans to close one of its three manufacturing plants in Puerto Rico by the end of next year.

  4. Janssen And Aduro Ink New Deal In Lung Cancer Immunotherapy
    10/21/2014

    Janssen Biotech and Aduro BioTech announced their second agreement to develop treatments for lung cancer using Aduro’s LADD immunotherapy platform.

  5. Batu Biologics Licenses Novel Oncology Peptide Drugs From UC San Diego
    10/21/2014

    Batu Biologics has acquired exclusive licensing rights to novel peptide drugs for oncology targets from the University of California San Diego (UCSD).

  6. ProMetic Seeks Orphan Status For Lead IPF Drug
    10/20/2014

    Biopharmaceutical company ProMetic Life Sciences announced its intent to pursue idiopathic pulmonary fibrosis (IPF) as an orphan indication for its lead drug candidate PBI-4050.

  7. New Multiple Myeloma Drug To Enter Clinical Trials
    10/20/2014

    Researchers at the Imperial College London have developed a new type of drug for treating multiple myeloma which will enter clinical trials in late 2015.

  8. Pall ForteBio Introduces Off-The-Shelf Dip And Read Anti-CHO HCP Detection Kit To Accelerate Drug Development
    10/20/2014

    Pall ForteBio LLC, a division of Pall Corp. and a leading supplier of instrumentation and analytics for accelerated drug discovery and development, has announced commercial availability of a new Dip and Read™ Anti-CHO (Chinese hamster ovary) Host Cell Protein (HCP) Detection Kit for quantitation of residual HCPs.

  9. SSB’s Production Facility Design For WuXi AppTec Receives Honorable Mention At The ISPE Facility Of The Year Awards 2014
    10/20/2014

    The WuXi AppTec bulk cell culture production facility designed by Sartorius Stedim Biotech (SSB), a leading international supplier of pharmaceutical and biotech equipment, received an honorable mention in the 2014 Facility of the Year Awards.

  10. Alzheimer's Research Breakthrough Could Accelerate Development Of New Treatments
    10/20/2014

    Scientists at Massachusetts General Hospital (MGH) have developed an ‘Alzheimer's-in-a-dish’ breakthrough, which will allow them to replace the current poorly performing animal models with an innovative laboratory culture system for studying Alzheimer's disease and discovering new treatments.

Newsletter Signup
Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.